Aflibercept in Treating Young Patients With Relapsed or Refractory Solid Tumors

Clinical trial NCT00622414 · COMPLETED

Trial details

NCT number: NCT00622414
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Unspecified Childhood Solid Tumor, Protocol Specific

Start date: 2008-04-01
Primary completion: 2010-02-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.